BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $279,000 | -17.0% | 4,338 | 0.0% | 0.07% | 0.0% |
| Q1 2022 | $336,000 | -54.8% | 4,338 | -50.0% | 0.07% | -10.5% |
| Q4 2021 | $744,000 | +113.2% | 8,676 | +100.0% | 0.08% | 0.0% |
| Q3 2021 | $349,000 | 0.0% | 4,338 | 0.0% | 0.08% | +20.6% |
| Q2 2021 | $349,000 | -4.6% | 4,338 | 0.0% | 0.06% | -6.0% |
| Q1 2021 | $366,000 | +5.2% | 4,338 | 0.0% | 0.07% | -9.5% |
| Q4 2020 | $348,000 | -0.3% | 4,338 | 0.0% | 0.07% | -19.6% |
| Q3 2020 | $349,000 | +11.1% | 4,338 | +18.9% | 0.09% | +15.0% |
| Q2 2020 | $314,000 | +5.4% | 3,649 | -0.5% | 0.08% | -13.0% |
| Q1 2020 | $298,000 | -2.9% | 3,669 | 0.0% | 0.09% | +61.4% |
| Q4 2019 | $307,000 | -4.4% | 3,669 | 0.0% | 0.06% | -18.6% |
| Q3 2019 | $321,000 | +6.6% | 3,669 | 0.0% | 0.07% | +11.1% |
| Q2 2019 | $301,000 | +1.3% | 3,669 | +0.5% | 0.06% | 0.0% |
| Q1 2019 | $297,000 | +8.4% | 3,649 | -12.3% | 0.06% | -3.1% |
| Q4 2018 | $274,000 | -14.6% | 4,160 | 0.0% | 0.06% | +3.2% |
| Q3 2018 | $321,000 | +4.6% | 4,160 | 0.0% | 0.06% | 0.0% |
| Q2 2018 | $307,000 | +24.8% | 4,160 | +10.1% | 0.06% | +21.2% |
| Q1 2018 | $246,000 | +0.8% | 3,778 | 0.0% | 0.05% | -23.5% |
| Q4 2017 | $244,000 | +3.0% | 3,778 | 0.0% | 0.07% | +1.5% |
| Q3 2017 | $237,000 | +3.5% | 3,778 | 0.0% | 0.07% | +19.6% |
| Q2 2017 | $229,000 | +16.8% | 3,778 | 0.0% | 0.06% | +21.7% |
| Q1 2017 | $196,000 | +16.7% | 3,778 | 0.0% | 0.05% | +9.5% |
| Q4 2016 | $168,000 | – | 3,778 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |